Craig Mayer, Nick WIlliams, Vojtech Huser
Lister Hill National Center for Biomedical Communications, National Library of Medicine, NIH, Bethesda, MD

See the full regCTG repository at https://github.com/lhncbc/CRI/tree/master/regCTG

To return to the list of conditions and view other reports go to https://lhncbc.github.io/CRI/regCTG/regCTG-condition_report_links.html


Study Counts

Type Study_count
Total_Studies 160
interventional 119
Observational 37
Registry 4

Studies over Time by Start Date

```

Interventional Trials

Intervention Type

intervention_type Study_Count
Drug 52
Behavioral 14
Drug|placebo 14
Biological 11
Other 8
Device 6
Behavioral|Other 2
Dietary Supplement|placebo 2
Procedure 2
Biological|Diagnostic Test 1
Biological|Drug 1
Biological|Drug|placebo 1
Biological|placebo 1
Device|placebo 1
Device|Procedure 1
Diagnostic Test 1
Genetic 1

Count of Studies by Intervention (normalized and mapped)

Interventions over Time

Yearly studies for each intervention by start date

Studies by Country

Country Study_Count
United States 23
NA 13
Canada 12
France 12
Brazil 3
Italy 3
Japan 3
United States|Argentina|Australia|Brazil|Canada|France|Germany|Italy|Mexico|Russian Federation|Spain|United Kingdom 3
Argentina|Australia|Austria|Belgium|Brazil|China|Czechia|Denmark|France|Germany|India|Israel|Italy|Japan|Mexico|Poland|Russian Federation|Spain|Turkey|United Kingdom 2
Australia 2
China 2
Finland 2
Germany 2
Netherlands 2
Sweden 2
Turkey 2
Argentina|Austria|Belgium|Brazil|Czechia|Denmark|France|Germany|India|Israel|Italy|Japan|Mexico|Poland|Russian Federation|Spain|Turkey|United Kingdom 1
Argentina|Canada|Chile|Czechia|Finland|France|Germany|Italy|Mexico|Netherlands|Poland|Russian Federation|Spain|United Kingdom 1
Argentina|Canada|Czechia|Finland|France|Germany|Italy|Russian Federation|Spain|United Kingdom 1
Australia|Belgium|Colombia|Czech Republic|France|Germany|Hungary|Italy|Latvia|Lithuania|Mexico|Netherlands|Norway|Poland|Russian Federation|Serbia|Slovakia|Slovenia|Spain 1
Austria|Belgium|France|Germany|Italy|Russian Federation|United Kingdom 1
France|Germany|Switzerland 1
Hungary 1
Israel 1
Serbia 1
Spain|United States|Argentina|Austria|Belgium|Brazil|Canada|France|Germany|Greece|Hungary|Israel|Italy|Netherlands|Peru|Poland|Russian Federation|Sweden|Switzerland|Turkey|United Kingdom 1
United States|Argentina|Australia|Belgium|Brazil|Canada|Chile|China|Germany|Israel|Mexico|Poland|Russian Federation|Slovakia|South Africa|Spain|Turkey|Ukraine|United Kingdom 1
United States|Argentina|Australia|Belgium|Brazil|Canada|Czech Republic|Denmark|Germany|Greece|Italy|Mexico|Netherlands|Norway|Poland|Slovakia|Spain|Sweden|United Kingdom 1
United States|Argentina|Australia|Belgium|Brazil|Canada|France|Germany|Italy|Mexico|Peru|Poland|Russian Federation|Spain|United Kingdom 1
United States|Argentina|Australia|Belgium|Brazil|Canada|Israel|Mexico|Poland|Russian Federation|Spain|Turkey|Ukraine|United Kingdom 1
United States|Argentina|Belgium|Brazil|Canada|France|Germany|Hungary|Israel|Italy|Netherlands|Norway|Peru|Poland|South Africa|Spain|Sweden|Switzerland|Turkey 1
United States|Argentina|Belgium|Brazil|France|Germany|Italy|Mexico|Peru|Russian Federation|South Africa|Spain 1
United States|Argentina|Belgium|Canada|Germany|Hungary|Poland|Spain 1
United States|Argentina|Brazil|Canada|Chile|Israel|Mexico|Russian Federation|South Africa 1
United States|Argentina|Brazil|Canada|Chile|Mexico|Russian Federation 1
United States|Argentina|Canada|Germany|Israel|Italy|Mexico|Russian Federation|Spain|United Kingdom 1
United States|Austria|Belgium|Brazil|Canada|France|Germany|Hungary|Israel|Italy|Netherlands|Poland|Russian Federation|Spain|Sweden|Turkey 1
United States|Austria|Brazil|France|Germany|Italy|Mexico|Peru|Portugal|Spain|Switzerland 1
United States|Belgium|Brazil|Canada|Denmark|France|Germany|Mexico|Peru|Portugal|Russian Federation|Slovakia|Slovenia|Spain|Sweden 1
United States|Belgium|Czech Republic|France|Germany|Italy|Slovakia|Spain 1
United States|Belgium|Germany|Italy|Poland|Russian Federation|South Africa|Spain|Turkey|United Kingdom 1
United States|Belgium|Germany|Italy|Poland|Russian Federation|Spain|Turkey 1
United States|Brazil|Mexico|Ukraine 1
United States|Chile|Costa Rica|Peru|Philippines|Russian Federation|Serbia|South Africa|Switzerland|Ukraine 1
United States|France|Italy|Netherlands|Spain|United Kingdom 1
United States|Germany|Hungary|Italy|Puerto Rico|Spain 1
United States|Germany|Poland|Slovakia 1

Sites per Study

Site_count Study_Count
1 57
2 4
3 5
4 3
5 2
6 3
7 3
8 1
9 1
10 2
11 1
12 1
13 1
14 1
15 1
16 2
17 1
19 1
20 2
24 1
30 1
31 2
32 1
33 1
34 1
35 1
36 1
37 2
38 1
39 1
42 2
50 1
54 1
55 1
58 1
69 1
73 2
74 1
92 1
103 2
129 1

Phase

Phase Study_Count
Phase 3 43
N/A 35
Phase 1 12
Phase 2 12
Phase 4 11
Phase 2/Phase 3 3
Early Phase 1 2
Phase 1/Phase 2 1

Number of Arms

Number_of_Arms Count_of_Studies
1 46
2 47
3 9
4 2
6 1
8 1
NA 13

Enrollment Metrics by Phase

Measure Early.Phase.1 N.A Phase.1 Phase.1.Phase.2 Phase.2 Phase.2.Phase.3 Phase.3 Phase.4
Min. 30 4.0000 6.00000 26 6.00000 24.00000 5.0000 12.0
1st Qu. 38 31.5000 21.25000 26 16.50000 29.00000 31.5000 40.5
Median 46 60.0000 34.00000 26 47.00000 34.00000 103.0000 85.0
Mean 46 103.6857 50.33333 26 57.91667 42.33333 117.4186 91.0
3rd Qu. 54 123.0000 52.50000 26 81.50000 51.50000 187.5000 136.0
Max. 62 600.0000 216.00000 26 192.00000 69.00000 340.0000 201.0

Trial Group Type

group_type Group_Count
Experimental 130
Active Comparator 28
Placebo Comparator 19
NA 13
Other 7
No Intervention 5

Intervention Model

intervention_model Study_Count
Parallel Assignment 56
Single Group Assignment 50
Crossover Assignment 6
NA 5
Factorial Assignment 1
Sequential Assignment 1

Primary Purpose

primary_purpose Study_Count
Treatment 93
Prevention 7
Diagnostic 5
Basic Science 4
Supportive Care 4
Other 2
NA 2
Device Feasibility 1
Health Services Research 1

Observational Studies

Studies by Country

Country Study_Count
NA 8
United States 7
France 5
Italy 2
Sweden 2
United Kingdom 2
Belgium 1
China 1
Denmark 1
Egypt 1
Germany 1
Japan 1
Norway 1
Russian Federation 1
United States|Australia|Austria|Czechia|Denmark|France|Germany|Greece|Hungary|Italy|Netherlands|Norway|Portugal|Puerto Rico|Slovakia|Spain|Sweden 1
United States|Austria|Brazil|Canada|Denmark|France|Germany|Greece|Hungary|Israel|Italy|Latvia|Mexico|Netherlands|Norway|Peru|Portugal|Puerto Rico|Romania|Russian Federation|Saudi Arabia|Slovakia|South Africa|Spain|United Kingdom 1
United States|Canada 1

Sites per Study

Site_count Study_Count
1 27
3 3
5 1
8 1
14 1
17 1
55 1
82 1
92 1

Enrollment Metrics

Measure Observational
Min 10.0000
1st Qu 95.0000
Median 150.0000
Mean 701.0811
3rd Qu 452.0000
Max 9000.0000

Observation Model

observational_model Study_Count
Cohort 25
Case-Control 5
Case-Only 4
Case Control 1
Ecologic or Community 1
Other 1

Time Perspective

time_perspective Study_Count
Prospective 23
Retrospective 8
Cross-Sectional 6

Registries

Studies by Country

Country Study_Count
United States 2
Belgium|France|Germany|Morocco|Switzerland 1
Canada 1

Sites per Study

Site_count Study_Count
1 2
14 1
44 1

Enrollment Metrics

Measure Registries
Min 300.0
1st Qu 3675.0
Median 7193.5
Mean 6138.5
3rd Qu 9657.0
Max 9867.0

Registry Model

observational_model Study_Count
Cohort 4

Time Perspective

time_perspective Study_Count
Prospective 4

Follow-up

target_duration Study_Count
10 Years 3
5 Years 1

Overview of Studies

Interventional Trials

#If less then 500 trials

nct_id brief_title link overall_status source primary_completion_date
NCT04088396 A Study of Baricitinib (LY3009104) in Participants From 1 Year to Less Than 18 Years Old With sJIA https://ClinicalTrials.gov/show/NCT04088396 Recruiting Eli Lilly and Company 2023-04-07
NCT03773978 A Study of Baricitinib in Participants From 2 Years to Less Than 18 Years Old With Juvenile Idiopathic Arthritis https://ClinicalTrials.gov/show/NCT03773978 Recruiting Eli Lilly and Company 2021-08-21
NCT03773965 A Study of Baricitinib in Participants From 1 Year to Less Than 18 Years Old With Juvenile Idiopathic Arthritis https://ClinicalTrials.gov/show/NCT03773965 Recruiting Eli Lilly and Company 2027-12-06
NCT03311854 A Study to Investigate the Safety and Efficacy of an Anti-IFN-gamma mAb in Children With Systemic Juvenile Idiopathic Arthritis (sJIA) Developing Macrophage Activation Syndrome/ Secondary Hemophagocytic Lymphohistiocytosis (MAS/sHLH) https://ClinicalTrials.gov/show/NCT03311854 Active, not recruiting NovImmune SA 2021-05-31
NCT03301883 A Study of Tocilizumab in Chinese Participants With Systemic Juvenile Idiopathic Arthritis (sJIA) https://ClinicalTrials.gov/show/NCT03301883 Recruiting Hoffmann-La Roche 2020-09-23
NCT03286933 Yoga Therapy for Adolescents With Juvenile Idiopathic Arthritis https://ClinicalTrials.gov/show/NCT03286933 Completed Children’s Hospital Los Angeles 2017-06-26
NCT03116763 The iPeer2Peer Program for Adolescents With Juvenile Idiopathic Arthritis https://ClinicalTrials.gov/show/NCT03116763 Recruiting The Hospital for Sick Children 2021-05-31
NCT03092427 Probiotic Treatment in Juvenile Idiopathic Arthritis (JIA) https://ClinicalTrials.gov/show/NCT03092427 Recruiting Assistance Publique - Hôpitaux de Paris 2020-05-31
NCT03069638 Intranasal Dexmedetomidine Sedation During Intra-articular Joint Injections in Pediatric Population https://ClinicalTrials.gov/show/NCT03069638 Recruiting University of Oulu 2021-06-30
NCT03031782 Secukinumab Safety and Efficacy in JPsA and ERA https://ClinicalTrials.gov/show/NCT03031782 Active, not recruiting Novartis 2020-06-16
NCT03008681 OHRQoL Evaluation After Functional Therapy in JIA Patients https://ClinicalTrials.gov/show/NCT03008681 Completed University of Messina 2016-09-30
NCT02991469 A Repeated Dose-finding Study of Sarilumab in Children and Adolescents With Systemic Juvenile Idiopathic Arthritis (SKYPS) https://ClinicalTrials.gov/show/NCT02991469 Recruiting Sanofi 2025-05-31
NCT02977416 Oxidation Rates of the Different Substrates During Exercise in Children and Adolescents With Juvenile Idiopathic Arthritis. Case-control Study and Cases Treated / Cases Not Treated With Anti-TNFα https://ClinicalTrials.gov/show/NCT02977416 Recruiting University Hospital, Clermont-Ferrand 2020-05-31
NCT02954718 Video-Based Task Oriented Activity Training in Patients With Juvenile Idiopathic Arthritis https://ClinicalTrials.gov/show/NCT02954718 Completed Istanbul University 2016-11-30
NCT02840175 Treatment Tapering in JIA With Inactive Disease https://ClinicalTrials.gov/show/NCT02840175 Active, not recruiting Assistance Publique - Hôpitaux de Paris 2019-10-29
NCT02776735 An Open-label, Ascending, Repeated Dose-finding Study of Sarilumab in Children and Adolescents With Polyarticular-course Juvenile Idiopathic Arthritis (pcJIA) https://ClinicalTrials.gov/show/NCT02776735 Recruiting Sanofi 2021-10-31
NCT02764346 iCanCope With Pain: Usability and Feasibility Testing of a Smartphone Application to Manage Pain in Youth With Arthritis https://ClinicalTrials.gov/show/NCT02764346 Completed The Hospital for Sick Children 2019-12-31
NCT02610166 Jointly Managing JIA Online: An Internet-based Psycho-educational Game for Children With JIA and Their Parents https://ClinicalTrials.gov/show/NCT02610166 Completed The Hospital for Sick Children 2019-03-31
NCT02592434 Efficacy Study Of Tofacitinib In Pediatric JIA Population https://ClinicalTrials.gov/show/NCT02592434 Completed Pfizer 2019-05-16
NCT01500551 Long-Term Safety Study Of Tofacinib In Patients With Juvenile Idiopathic Arthritis https://ClinicalTrials.gov/show/NCT01500551 Recruiting Pfizer 2024-11-15
NCT02522507 A Peer E-mentoring Intervention to Improve Employment https://ClinicalTrials.gov/show/NCT02522507 Recruiting Holland Bloorview Kids Rehabilitation Hospital 2019-04-30
NCT02505828 ARTEMIS Synovial Markers in Arthritis Childhood https://ClinicalTrials.gov/show/NCT02505828 Completed University Hospital, Montpellier 2018-04-30
NCT02479373 Exercise and Body Composition in Juvenile Idiopathic Arthritis https://ClinicalTrials.gov/show/NCT02479373 Completed Johns Hopkins University 2015-10-31
NCT02453880 Web-based CBT for Symptoms of Mild-to-Moderate Anxiety and Depression in Youth With Chronic Illness https://ClinicalTrials.gov/show/NCT02453880 Completed Stanford University 2015-05-31
NCT02398435 Therapeutic Use of Tadekinig Alfa in Adult-onset Still’s Disease https://ClinicalTrials.gov/show/NCT02398435 Completed AB2 Bio Ltd. 2016-06-30
NCT02396212 Study of Efficacy and Safety of Canakinumab in Japanese Patients With SJIA https://ClinicalTrials.gov/show/NCT02396212 Completed Novartis 2017-03-07
NCT02334748 A Study of Canakinumab in Patients With Systemic Juvenile Idiopathic Arthritis or Hereditary Periodic Fevers Who Participated in the CACZ885G2301E1, CACZ885G2306 or CACZ885N2301 Studies https://ClinicalTrials.gov/show/NCT02334748 Completed Novartis 2018-08-31
NCT02296424 ß-SPECIFIC 4 Patients: Study of Pediatric EffiCacy and Safety wIth FIrst-line Use of Canakinumab https://ClinicalTrials.gov/show/NCT02296424 Completed Novartis 2016-10-14
NCT02277444 A Study to Evaluate the Pharmacokinetics, Efficacy and Safety of Intravenous Golimumab in Pediatric Participants With Active Polyarticular Course Juvenile Idiopathic Arthritis Despite Methotrexate Therapy https://ClinicalTrials.gov/show/NCT02277444 Active, not recruiting Janssen Research & Development, LLC 2018-07-09
NCT02263703 Immunogenicity of HPV Vaccine in Immunosuppressed Children https://ClinicalTrials.gov/show/NCT02263703 Completed The University of New South Wales 2016-02-29
NCT02196480 23-valent Polysaccharide Pneumococcal Vaccine in Juvenile Idiopathic Arthritis Patients Under Anti-TNF Therapy https://ClinicalTrials.gov/show/NCT02196480 Completed University of Sao Paulo 2011-06-30
NCT02191722 “Medikidz Explain JIA Comic Book- Hebrew” https://ClinicalTrials.gov/show/NCT02191722 Completed Rabin Medical Center 2016-05-31
NCT02165345 Extension Study Evaluating the Safety and Efficacy of Subcutaneous Tocilizumab (RoActemra/Actemra) Administration in Systemic and Polyarticular-Course Juvenile Idiopathic Arthritis https://ClinicalTrials.gov/show/NCT02165345 Active, not recruiting Hoffmann-La Roche 2020-09-15
NCT02067962 Identification of Genes Involved in Juvenile Idiopathic Arthritis by Wholel Exome Sequencing https://ClinicalTrials.gov/show/NCT02067962 Completed University Hospital, Montpellier 2014-09-24
NCT02052167 Human Factors Study of Methotrexate Prefilled Pen (50 mg/mL) in Patients With Juvenile Idiopathic Arthritis https://ClinicalTrials.gov/show/NCT02052167 Completed medac GmbH 2014-08-31
NCT02030613 Effective Dose of Etanercept in Patients Treated for Juvenile Idiopathic Arthritis https://ClinicalTrials.gov/show/NCT02030613 Completed Assistance Publique - Hôpitaux de Paris 2017-02-28
NCT02001844 Foot Orthoses (FOs) on Pain, Quality of Life and the Gait With Children Diagnosed With JIA https://ClinicalTrials.gov/show/NCT02001844 Completed University of Newcastle, Australia 2012-11-30
NCT01986400 Virtual Peer-to-Peer (VP2P) Support Mentoring for Juvenile Idiopathic Arthritis (JIA): A Pilot RCT https://ClinicalTrials.gov/show/NCT01986400 Completed The Hospital for Sick Children 2015-05-31
NCT01904292 A Study of Subcutaneously Administered Tocilizumab in Participants With Systemic Juvenile Idiopathic Arthritis https://ClinicalTrials.gov/show/NCT01904292 Completed Hoffmann-La Roche 2017-06-13
NCT01904279 A Study of Subcutaneously (SC) Administered Tocilizumab (TCZ) in Participants With Polyarticular-Course Juvenile Idiopathic Arthritis (pJIA) https://ClinicalTrials.gov/show/NCT01904279 Completed Hoffmann-La Roche 2016-05-31
NCT01844518 Pharmacokinetics, Efficacy and Safety of Abatacept Administered Subcutaneously (SC) in Children and Adolescents With Active Polyarticular Juvenile Idiopathic Arthritis (pJIA) and Inadequate Response (IR) to Biologic or Non Biologic Disease Modifying Anti-rheumatic Drugs (DMARDs) https://ClinicalTrials.gov/show/NCT01844518 Active, not recruiting Bristol-Myers Squibb 2015-03-12
NCT01835470 Efficacy, Safety, Pharmacokinetics and Immunogenicity Study of Abatacept Administered Intravenously to Treat Active Polyarticular-course Juvenile Idiopathic Arthritis in Japan https://ClinicalTrials.gov/show/NCT01835470 Completed Bristol-Myers Squibb 2015-11-24
NCT01803321 Study to Evaluate the Safety and Tolerability of Two Doses of Rilonacept in Pediatric Subjects With Active Systemic Juvenile Idiopathic Arthritis (SJIA) https://ClinicalTrials.gov/show/NCT01803321 Completed Regeneron Pharmaceuticals 2008-06-30
NCT01734382 A Study of Decreased Dose Frequency in Participants With Systemic Juvenile Arthritis Who Experience Laboratory Abnormalities During Treatment With RoActemra/Actemra (Tocilizumab) https://ClinicalTrials.gov/show/NCT01734382 Completed Hoffmann-La Roche 2019-10-09
NCT01727986 An Extension Long-Term Study of RoActemra/Actemra (Tocilizumab) in Patients With Polyarticular Juvenile Idiopathic Arthritis Who Completed The WA19977 Study https://ClinicalTrials.gov/show/NCT01727986 Completed Hoffmann-La Roche 2015-11-30
NCT01673919 A Long-Term Extension Study of RoActemra/Actemra (Tocilizumab) in Patients With Juvenile Idiopathic Arthritis From France Who Completed WA19977 Core Study https://ClinicalTrials.gov/show/NCT01673919 Completed Hoffmann-La Roche 2014-01-31
NCT01667471 A Long-Term Extension Study of RoActemra/Actemra (Tocilizumab) in Patients With Juvenile Idiopathic Arthritis Who Completed WA19977 Core Study https://ClinicalTrials.gov/show/NCT01667471 Completed Hoffmann-La Roche 2013-08-31
NCT01572896 An Internet-based Self-management Program for Adolescents With Arthritis https://ClinicalTrials.gov/show/NCT01572896 Completed The Hospital for Sick Children 2016-03-31
NCT01563185 Open-label Safety and Pharmacokinetic Study of DUEXIS® (Ibuprofen and Famotidine) Tablets in Juvenile Idiopathic Arthritis https://ClinicalTrials.gov/show/NCT01563185 Completed Horizon Pharma Ireland, Ltd., Dublin Ireland 2015-03-31
NCT01550003 Pediatric Arthritis Study of Certolizumab Pegol https://ClinicalTrials.gov/show/NCT01550003 Active, not recruiting UCB Pharma 2023-06-30
NCT01544114 A Safety Study of VIMOVO in Adolescents With Juvenile Idiopathic Arthritis (JIA) https://ClinicalTrials.gov/show/NCT01544114 Completed Horizon Pharma Ireland, Ltd., Dublin Ireland 2015-02-28
NCT01541917 Efficacy of Web-based Pain Self-management for Adolescents With Juvenile Idiopathic Arthritis https://ClinicalTrials.gov/show/NCT01541917 Completed Children’s Mercy Hospital Kansas City 2016-04-30
NCT01513902 Pharmacokinetics Of CP-690,550 In Pediatric Patients With Juvenile Idiopathic Arthritis (JIA) https://ClinicalTrials.gov/show/NCT01513902 Completed Pfizer 2015-12-31
NCT01455701 A Study to Evaluate Pharmacokinetics and Safety of Tocilizumab (RoActemra/Actemra) in Participants Less Than 2 Years Old With Active Systemic Juvenile Idiopathic Arthritis (sJIA) https://ClinicalTrials.gov/show/NCT01455701 Completed Hoffmann-La Roche 2016-07-28
NCT01385826 Effect of Adalimumab for the Treatment of Uveitis in Juvenile Idiopathic Arthritis https://ClinicalTrials.gov/show/NCT01385826 Completed Assistance Publique - Hôpitaux de Paris 2014-11-04
NCT01358383 Assessment of Pharmacokinetics of a Single Oral Dose of VIMOVO in Healthy Adult Volunteers https://ClinicalTrials.gov/show/NCT01358383 Completed AstraZeneca 2011-06-30
NCT04337437 Clinical Study of Genakumab for Injection in Chinese Healthy Volunteers https://ClinicalTrials.gov/show/NCT04337437 Recruiting GeneScience Pharmaceuticals Co., Ltd. 2020-09-30
NCT04205500 Treatment With Specific Carbohydrate Diet in Children With Juvenile Idiopathic Arthritis https://ClinicalTrials.gov/show/NCT04205500 Recruiting Uppsala University 2021-09-01
NCT04169828 The Ondansetron Premedication Trial in Juvenile Idiopathic Arthritis https://ClinicalTrials.gov/show/NCT04169828 Recruiting University of British Columbia 2022-01-01
NCT04168034 iParent2Parent Program for Parents of Children With Juvenile Idiopathic Arthritis https://ClinicalTrials.gov/show/NCT04168034 Recruiting The Hospital for Sick Children 2021-09-01
NCT04167488 Assessment of Physical Activity Among Juvenile Idiopathic Arthritis Children Performed With Actigraphy https://ClinicalTrials.gov/show/NCT04167488 Recruiting Centre Hospitalier Universitaire de Besancon 2019-12-31
NCT04133662 Sleep & Pain in Juvenile Arthritis https://ClinicalTrials.gov/show/NCT04133662 Recruiting The Hospital for Sick Children 2021-03-31
NCT04066205 Sleep Self-Management Intervention for Children With Juvenile Idiopathic Arthritis https://ClinicalTrials.gov/show/NCT04066205 Recruiting University of Washington 2020-12-30
NCT04018599 Comparison of PK and Tolerability of MSB11022 Administered by AI or PFS https://ClinicalTrials.gov/show/NCT04018599 Completed Fresenius Kabi SwissBioSim GmbH 2020-03-17
NCT03913962 Health and Exercise Response in Children With Chronic and Auto-immune Pathologies https://ClinicalTrials.gov/show/NCT03913962 Recruiting University Hospital, Clermont-Ferrand 2028-12-31
NCT03858504 Yoga Versus Home Exercise Program in Children With Enthesitis Related Arthritis https://ClinicalTrials.gov/show/NCT03858504 Completed Pamukkale University 2019-07-31
NCT03780959 Safety and Efficacy of Etanercept (Recombinant Human Tumor Necrosis Factor Receptor Fusion Protein [TNFR:Fc]) in Children With Juvenile Rheumatoid Arthritis (JRA) https://ClinicalTrials.gov/show/NCT03780959 Completed Amgen 1998-07-08
NCT03769168 An Extension Study of Subcutaneous Secukinumab in Patients With Juvenile Psoriatic Arthritis (JPsA) and Enthesitis Related Arthritis (ERA) https://ClinicalTrials.gov/show/NCT03769168 Recruiting Novartis 2024-10-02
NCT03731520 Determination of Exercise Behavior in Patients With Juvenile Idiopathic Arthritis https://ClinicalTrials.gov/show/NCT03731520 Active, not recruiting Istanbul University 2018-12-30
NCT03728478 STep-up and Step-down Therapeutic Strategies in Childhood ARthritiS https://ClinicalTrials.gov/show/NCT03728478 Recruiting Istituto Giannina Gaslini 2021-03-31
NCT03725007 A Study to Evaluate the Pharmacokinetics, Safety, and Tolerability of Upadacitinib in Pediatric Subjects With Polyarticular Course Juvenile Idiopathic Arthritis https://ClinicalTrials.gov/show/NCT03725007 Recruiting AbbVie 2021-07-31
NCT03430388 Yellow Fever Vaccine in Patients With Rheumatic Diseases https://ClinicalTrials.gov/show/NCT03430388 Completed University of Sao Paulo General Hospital 2018-03-24
NCT01166750 Jointstrong Intervention for Juvenile Arthritis https://ClinicalTrials.gov/show/NCT01166750 Completed University of Kansas Medical Center 2011-03-31
NCT01166282 A Study of the Efficacy and Safety of Adalimumab in Pediatric Subjects With Enthesitis Related Arthritis https://ClinicalTrials.gov/show/NCT01166282 Completed AbbVie 2012-11-30
NCT01033656 Treatment of Refractory Adult-onset Still’s Disease With Anakinra: a Randomized Study https://ClinicalTrials.gov/show/NCT01033656 Completed University of Helsinki 2010-03-31
NCT01011179 Internet Self-Management Program With Telephone Support for Adolescents With Arthritis https://ClinicalTrials.gov/show/NCT01011179 Completed The Hospital for Sick Children 2009-06-30
NCT00988221 A Study of Tocilizumab in Patients With Active Polyarticular Juvenile Idiopathic Arthritis https://ClinicalTrials.gov/show/NCT00988221 Completed Hoffmann-La Roche 2011-11-30
NCT00962741 Study Evaluating Etanercept in 3 Subtypes of Childhood Arthritis https://ClinicalTrials.gov/show/NCT00962741 Completed Pfizer 2011-06-30
NCT00891046 An Open-label Extension Study of Canakinumab in Patients With Systemic Juvenile Idiopathic Arthritis and Active Systemic Manifestations Manifestations and Response Characterization Study in Canakinumab Treatment-naïve Patients With Active SJIA With and Without Fever. https://ClinicalTrials.gov/show/NCT00891046 Completed Novartis 2014-12-31
NCT00889863 Flare Prevention Study of Canakinumab in Patients With Active Systemic Juvenile Idiopathic Arthritis (SJIA) https://ClinicalTrials.gov/show/NCT00889863 Completed Novartis 2011-09-30
NCT03984669 (1,3)-Béta-D-Glucan Levels at Diagnosis of Juvenile Idiopathic Arthritis and Its Correlation With Activity’s Disease : a Cohort Sudy https://ClinicalTrials.gov/show/NCT03984669 Recruiting Centre Hospitalier Universitaire, Amiens 2020-06-30
NCT00815282 Immune Response After Human Papillomavirus Vaccination in Patients With Autoimmune Disease https://ClinicalTrials.gov/show/NCT00815282 Completed UMC Utrecht 2015-01-31
NCT00807846 A Study To Evaluate The Effects Of Celecoxib (Celebrex®) Or Naproxen On Blood Pressure In Pediatric Subjects https://ClinicalTrials.gov/show/NCT00807846 Completed Pfizer 2012-12-31
NCT03833271 The Efficacy of Influenza Vaccine Program in Children With Juvenile Idiopathic Arthritis. A Single Centre Results From Hungary https://ClinicalTrials.gov/show/NCT03833271 Completed University of Pecs 2019-09-30
NCT01015547 Aggressive Combination Drug Therapy in Very Early Polyarticular Juvenile Idiopathic Arthritis https://ClinicalTrials.gov/show/NCT01015547 Completed Helsinki University Central Hospital 2007-11-30
NCT00792233 Determining Predictors of Safe Discontinuation of Anti-TNF Treatment in JIA https://ClinicalTrials.gov/show/NCT00792233 Completed Children’s Hospital Medical Center, Cincinnati 2013-10-31
NCT00775437 Active Juvenile Idiopathic Arthritis (JIA) Compassionate Use https://ClinicalTrials.gov/show/NCT00775437 Completed AbbVie 2013-03-31
NCT00731965 Safety and Efficacy of Measles, Mumps, Rubella Vaccination in Juvenile Idiopathic Arthritis https://ClinicalTrials.gov/show/NCT00731965 Completed UMC Utrecht 2012-05-31
NCT00690573 Safety, Efficacy, and Pharmacokinetics of Adalimumab in Japanese Children With Juvenile Rheumatoid Arthritis https://ClinicalTrials.gov/show/NCT00690573 Completed Abbott 2010-03-31
NCT00652925 A Study to Evaluate the Efficacy and Safety of Celecoxib Suspension Compared to Naproxen Suspension in Patients With JRA https://ClinicalTrials.gov/show/NCT00652925 Completed Pfizer 2004-04-30
NCT00642460 A Study of RoActemra/Actemra (Tocilizumab) in Patients With Active Systemic Juvenile Idiopathic Arthritis (JIA) https://ClinicalTrials.gov/show/NCT00642460 Completed Hoffmann-La Roche 2009-09-30
NCT00570934 Supplementation With Vitamin D, Calcium or Both on Calcium Absorption and Bone Mineral Content in Children With JRA https://ClinicalTrials.gov/show/NCT00570934 Completed University of Missouri-Columbia 2002-02-28
NCT00570661 Phase II, Open Label, International, Multicentre Clinical Trial to Investigate Safety and Efficacy of Oral ITF2357 in Patients With Active Systemic Onset Juvenile Idiopathic Arthritis (SOJIA) https://ClinicalTrials.gov/show/NCT00570661 Completed Italfarmaco 2008-08-31
NCT00534495 Safety and Effectiveness of Rilonacept for Treating Systemic Juvenile Idiopathic Arthritis in Children and Young Adults https://ClinicalTrials.gov/show/NCT00534495 Completed Montefiore Medical Center 2013-06-30
NCT00487565 Clinical Investigation of the LCS® Complete Posterior Stabilized Mobile-bearing Total Knee System https://ClinicalTrials.gov/show/NCT00487565 Completed DePuy Orthopaedics 2011-02-28
NCT00465504 Comparison of Two Different Methods of Delivering Local Analgesia During Intra-articular Corticosteroid Injections in Children With Juvenile Idiopathic Arthritis https://ClinicalTrials.gov/show/NCT00465504 Completed University of British Columbia 2007-12-31
NCT00443430 Trial of Early Aggressive Drug Therapy in Juvenile Idiopathic Arthritis https://ClinicalTrials.gov/show/NCT00443430 Completed Seattle Children’s Hospital 2010-10-31
NCT00426218 Safety, Efficacy and Pharmacokinetics of Subcutaneous ACZ885 in Patients With Systemic Juvenile Idiopathic Arthritis (SJIA) https://ClinicalTrials.gov/show/NCT00426218 Completed Novartis 2010-03-31
NCT00420251 Efficacy and Safety of Growth Hormone Treatment in Juvenile Idiopathic Arthritis https://ClinicalTrials.gov/show/NCT00420251 Completed Ludwig-Maximilians - University of Munich NA
NCT00339157 Interleukin-1 Receptor Antagonist (IL-1RA) (ANAKINRA) IN SEVERE SYSTEMIC-ONSET JUVENILE IDIOPATHIC ARTHRITIS https://ClinicalTrials.gov/show/NCT00339157 Completed Institut National de la Santé Et de la Recherche Médicale, France NA
NCT00289107 Randomized Fixed Bearing vs Mobile Bearing Cruciate Substituting TKA https://ClinicalTrials.gov/show/NCT00289107 Completed DePuy Orthopaedics 2009-09-30
NCT00289094 Randomized Fixed Bearing vs Mobile Bearing Cruciate Retaining TKA https://ClinicalTrials.gov/show/NCT00289094 Completed DePuy Orthopaedics 2009-09-30
NCT00279747 A One Year Double-blind Trial to Investigate the Efficacy and Safety of Meloxicam Oral Suspension in Juvenile Rheumatoid Arthritis (JRA/JIA) https://ClinicalTrials.gov/show/NCT00279747 Completed Boehringer Ingelheim 2003-01-31
NCT00213187 PEAK Study (Physical Exercise and Activity in Kids) https://ClinicalTrials.gov/show/NCT00213187 Completed The Hospital for Sick Children NA
NCT00144664 Study of MRA for Polyarticular Juvenile Idiopathic Arthritis (pJIA) https://ClinicalTrials.gov/show/NCT00144664 Completed Chugai Pharmaceutical 2005-04-30
NCT00144625 Long-term Treatment Study of MRA for Polyarticular Juvenile Idiopathic Arthritis (pJIA) https://ClinicalTrials.gov/show/NCT00144625 Completed Chugai Pharmaceutical 2005-07-31
NCT00144612 Long-term Treatment Study of MRA for Systemic Juvenile Idiopathic Arthritis (sJIA) https://ClinicalTrials.gov/show/NCT00144612 Completed Chugai Pharmaceutical 2005-06-30
NCT00144599 Study of MRA for Systemic Juvenile Idiopathic Arthritis (sJIA) https://ClinicalTrials.gov/show/NCT00144599 Completed Chugai Pharmaceutical NA
NCT00130637 Human Anti-Tac (Daclizumab) to Treat Juvenile Idiopathic Arthritis (JIA)-Associated Uveitis https://ClinicalTrials.gov/show/NCT00130637 Completed National Institutes of Health Clinical Center (CC) 2008-05-31
NCT00095173 BMS-188667 in Children and Adolescents With Juvenile Rheumatoid Arthritis https://ClinicalTrials.gov/show/NCT00095173 Completed Bristol-Myers Squibb 2006-06-30
NCT00001614 The Safety and Efficacy of Chicken Type II Collagen on Uveitis Associated With Juvenile Rheumatoid Arthritis https://ClinicalTrials.gov/show/NCT00001614 Completed National Institutes of Health Clinical Center (CC) NA
NCT00048542 Study of Human Anti-TNF Monoclonal Antibody Adalimumab in Children With Polyarticular Juvenile Idiopathic Arthritis (JIA) https://ClinicalTrials.gov/show/NCT00048542 Completed Abbott 2005-01-31
NCT00037648 Juvenile Rheumatoid Arthritis https://ClinicalTrials.gov/show/NCT00037648 Completed Swedish Orphan Biovitrum 2003-11-30
NCT00036374 A Study of the Safety and Effectiveness of Infliximab (Remicade) in Patients With Juvenile Rheumatoid Arthritis https://ClinicalTrials.gov/show/NCT00036374 Completed Centocor, Inc. NA
NCT00034853 Meloxicam [Mobic] in Juvenile Rheumatoid Arthritis (JRA) https://ClinicalTrials.gov/show/NCT00034853 Completed Boehringer Ingelheim 2003-06-30
NCT00010335 Pilot Study of Total Body Irradiation in Combination With Cyclophosphamide, Anti-thymocyte Globulin, and Autologous CD34-Selected Peripheral Blood Stem Cell Transplantation in Children With Refractory Autoimmune Disorders https://ClinicalTrials.gov/show/NCT00010335 Completed Fred Hutchinson Cancer Research Center 2010-07-31
NCT00000429 Calcium Supplements for Bone Health in Juvenile Rheumatoid Arthritis https://ClinicalTrials.gov/show/NCT00000429 Completed Children’s Hospital Medical Center, Cincinnati NA
NCT00001862 TNRF:Fc to Treat Eye Inflammation in Juvenile Rheumatoid Arthritis https://ClinicalTrials.gov/show/NCT00001862 Completed National Institutes of Health Clinical Center (CC) NA
NCT00004420 Study of Gammalinolenic Acid for Juvenile Rheumatoid Arthritis https://ClinicalTrials.gov/show/NCT00004420 Completed FDA Office of Orphan Products Development NA

Observational Studiess

#If less then 500 studies

nct_id brief_title link overall_status source primary_completion_date
NCT03383263 A Study to Assess Persistence, Adherence and Changes in Disease Activity in the Children Population of Juvenile Arthritis Patients Treated With Adalimumab (HUMIRA®) https://ClinicalTrials.gov/show/NCT03383263 Active, not recruiting AbbVie 2021-03-31
NCT03276650 Admission of Adult-onset Still Disease Patients in the ICU https://ClinicalTrials.gov/show/NCT03276650 Completed Central Hospital, Nancy, France 2018-06-01
NCT02824978 Therapeutic Alliance is it Associated With Better Compliance Amongst Children With Juvenile Idiopathic Arthritis ? https://ClinicalTrials.gov/show/NCT02824978 Completed University Hospital, Brest 2018-01-01
NCT02784808 Retrospective Analysis of Pulmonary Arterial Hypertension (PAH) and Related Complications in Juvenile Idiopathic Arthritis (JIA) Participants Treated With Biologic and Non-biologic Disease-modifying Anti-rheumatic Drugs (DMARDs) https://ClinicalTrials.gov/show/NCT02784808 Completed Hoffmann-La Roche 2012-12-31
NCT02684695 Juvenile Arthritis Quantitative Imaging https://ClinicalTrials.gov/show/NCT02684695 Recruiting University College London Hospitals 2021-01-31
NCT02593006 Start Time Optimization of Biologics in Polyarticular JIA https://ClinicalTrials.gov/show/NCT02593006 Completed Hackensack Meridian Health 2019-09-30
NCT00055055 Study of Families With Twins or Siblings Discordant for Rheumatic Disorders https://ClinicalTrials.gov/show/NCT00055055 Recruiting National Institutes of Health Clinical Center (CC) NA
NCT02528435 Understanding Methotrexate Induced Gastrointestinal Intolerance in Juvenile Idiopathic Arthritis and Childhood Leukemia https://ClinicalTrials.gov/show/NCT02528435 Completed University of Aarhus 2017-08-31
NCT02223195 Biomarkers in Saliva in Children With Juvenil Idiopathic Arthritis https://ClinicalTrials.gov/show/NCT02223195 Recruiting Folktandvården Stockholms län AB 2020-03-31
NCT02218892 Prediction of Temporomandibular Involvement in Juvenile Idiopathic Arthritis https://ClinicalTrials.gov/show/NCT02218892 Active, not recruiting Folktandvården Stockholms län AB 2017-08-31
NCT02143986 Glycosylated Ferritin in Macrophagic Activation Syndromes https://ClinicalTrials.gov/show/NCT02143986 Recruiting Brugmann University Hospital 2020-12-31
NCT02141984 Surveillance of Humira in Korean JIA Patients https://ClinicalTrials.gov/show/NCT02141984 Completed AbbVie 2016-04-30
NCT01304420 Ultrasonography in Juvenile Idiopathic Arthritis https://ClinicalTrials.gov/show/NCT01304420 Completed University of Aarhus 2011-11-30
NCT01905319 Juvenile Idiopathic Arthritis in Children in Estonia. https://ClinicalTrials.gov/show/NCT01905319 Completed University of Tartu 2000-12-31
NCT01412021 Special Investigation (All Case Survey) in Patients With Juvenile Idiopathic Arthritis https://ClinicalTrials.gov/show/NCT01412021 Completed AbbVie 2018-04-02
NCT01399281 Pharmacovigilance in Juvenile Idiopathic Arthritis Patients Treated With Biologic Agents and/or Methotrexate https://ClinicalTrials.gov/show/NCT01399281 Recruiting Istituto Giannina Gaslini 2021-12-31
NCT01357668 An Observational Registry of Abatacept in Patients With Juvenile Idiopathic Arthritis https://ClinicalTrials.gov/show/NCT01357668 Recruiting Bristol-Myers Squibb 2029-12-31
NCT04407923 Drug Management of Juvenile Idiopathic Arthritis in Covid-19 Context : Impact on Therapeutical Managment https://ClinicalTrials.gov/show/NCT04407923 Recruiting University Hospital, Brest 2020-11-25
NCT04216498 Psychosocial Outcomes and Transition Readiness in JIA https://ClinicalTrials.gov/show/NCT04216498 Completed Sheffield Children’s NHS Foundation Trust 2018-04-18
NCT04200833 Golimumab in Juvenile Idiopathic Arthritis-associated Uveitis Failing Adalimumab https://ClinicalTrials.gov/show/NCT04200833 Active, not recruiting Medical University of Graz 2020-10-01
NCT03932344 Long-term Safety Study of Kineret® in Patients With Systemic Juvenile Idiopathic Arthritis (SJIA) https://ClinicalTrials.gov/show/NCT03932344 Completed Swedish Orphan Biovitrum 2019-08-31
NCT03904459 Jaw, Mouth and Bone Health, and Quality of Life in Children With Juvenile Idiopathic Arthritis (JIA) https://ClinicalTrials.gov/show/NCT03904459 Active, not recruiting Haukeland University Hospital 2018-08-17
NCT03892135 Representation and Medication Use in Juvenile Idiopathic Arthritis https://ClinicalTrials.gov/show/NCT03892135 Completed University Hospital, Montpellier 2017-10-01
NCT03835624 Interleukin 33 in Juvenile Idiopathic Arthritis Patients https://ClinicalTrials.gov/show/NCT03835624 Completed Benha University 2019-11-20
NCT03769558 A Study of Juvenile Idiopathic Arthritis Patients Given Abatacept and the Number of Infections or Malignancies That Occur https://ClinicalTrials.gov/show/NCT03769558 Completed Bristol-Myers Squibb 2016-09-30
NCT03618680 Fatigue and Sleep in Children and Adolescents With Juvenile Idiopathic Arthritis: A Cross-Sectional Study https://ClinicalTrials.gov/show/NCT03618680 Completed Istanbul University 2018-03-01
NCT03510442 Natural History, Genetics, and Pathophysiology of Systemic Juvenile Idiopathic Arthritis, Adult-Onset Still’s Disease, and Related Conditions https://ClinicalTrials.gov/show/NCT03510442 Recruiting National Institutes of Health Clinical Center (CC) 2040-12-31
NCT03452735 Fertility Study of Women With Chronic Inflammatory Rheumatism https://ClinicalTrials.gov/show/NCT03452735 Recruiting University Hospital, Toulouse 2019-07-31
NCT01145352 Enbrel-Juvenile Idiopathic Arthritis (JIA) Use Results Survey [All-Case Surveillance] https://ClinicalTrials.gov/show/NCT01145352 Completed Pfizer 2013-10-31
NCT01044823 Use of Thermal and 3D Imaging to Quantify Arthritis https://ClinicalTrials.gov/show/NCT01044823 Completed University of Pittsburgh 2011-03-31
NCT02524340 Patient Centered Adaptive Treatment Strategies Using Bayesian Causal Inference https://ClinicalTrials.gov/show/NCT02524340 Completed Children’s Hospital Medical Center, Cincinnati 2019-01-31
NCT03006991 Study of Methotrexate Given to Juvenile Idiopathic Arthritis Patients Based on Pharmacogenomics and Pharmacometrics https://ClinicalTrials.gov/show/NCT03006991 Recruiting Guangzhou Women and Children’s Medical Center 2020-12-31
NCT01469897 Cost of Care for Juvenile Idiopathic Arthritis https://ClinicalTrials.gov/show/NCT01469897 Completed The Cleveland Clinic 2014-12-31
NCT00783510 Juvenile Idiopathic Arthritis (JIA) Registry https://ClinicalTrials.gov/show/NCT00783510 Active, not recruiting AbbVie 2024-02-06
NCT00762879 Spine Quantitative Computed Tomography (QCT) https://ClinicalTrials.gov/show/NCT00762879 Completed Children’s Hospital of Philadelphia 2014-01-31
NCT00404482 Cyclosporine A in the Treatment of Juvenile Idiopathic Arthritis (JIA) Associated Chronic Anterior Uveitis https://ClinicalTrials.gov/show/NCT00404482 Completed St. Franziskus Hospital NA
NCT00078793 Registry of Etanercept (Enbrel®) In Children With Juvenile Rheumatoid Arthritis https://ClinicalTrials.gov/show/NCT00078793 Completed Amgen 2008-01-31

Registries

#If less then 500 registries

nct_id brief_title link overall_status source primary_completion_date
NCT02377245 Juvenile Inflammatory Rheumatism (JIR) Cohorte https://ClinicalTrials.gov/show/NCT02377245 Enrolling by invitation University of Lausanne Hospitals 2021-12-31
NCT01697254 The CARRA Registry https://ClinicalTrials.gov/show/NCT01697254 Completed Duke University 2015-10-31
NCT03840928 AR-Power Patient Powered Research Network https://ClinicalTrials.gov/show/NCT03840928 Recruiting Global Healthy Living Foundation 2025-03-01
NCT03245801 CAPRI National Juvenile Idiopathic Arthritis Registry https://ClinicalTrials.gov/show/NCT03245801 Recruiting University of British Columbia 2026-02-01